The International CAR T-cell therapy market is experiencing a period of rapid growth. This expansion can be attributed to several factors, including the rising prevalence of hematological malignancies, developments in cell therapy, and supportive regulatory approvals. The market is classified by category of CAR T-cell therapy, indication, phase of … Read More